Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe Hemophilia A in Italy.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2194803
Abstract: Introduction: rVIII-SingleChain, a recombinant factor VIII (rFVIII), has demonstrated safety and efficacy in patients with hemophilia A in clinical trials and real-world evidence. This analysis aimed to estimate the potential budget impact of increasing the… read more here.
Keywords: rviii singlechain; singlechain; analysis; budget impact ... See more keywords